Non–HDL cholesterol and remnant cholesterol are better indicators of atherosclerotic cardiovascular disease risk than LDL cholesterol in patients with chronic kidney disease

Key Points

• Non-HDL cholesterol and remnant cholesterol are more effective indicators of atherosclerotic cardiovascular disease risk than LDL cholesterol.
• In chronic kidney disease patients, focusing on non-HDL cholesterol gives improved risk assessment, with significant implications for patient management.
• This assessment was based on data from patients with chronic kidney disease, emphasizing specific lipid profile changes associated with cardiovascular risk.
• Highlights the need to prioritize non-HDL and remnant cholesterol measurements in clinical practice for better cardiovascular health outcomes.